Stepping out of antiquity: An update on emerging drugs for the treatment of polycythemia vera.

导出 LinkOut

翻译打印收藏纠错

作者： Franco,Castillo Tokumori ^[1] ; Rami,Komrokji ^[2] ; Andrew T,Kuykendall ^[2]

作者单位： Internal Medicine,University of South Florida, College of Medicine, Tampa, USA. ^[1] Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, USA. ^[2]

关键词 Epigenetic modification hepcidin interferon jak inhibition jak/stat pathway mdm2 inhibition myeloproliferative neoplasms polycythemia vera rare disease

主题词人类(Humans);药用制剂(Pharmaceutical Preparations);真性红细胞增多症(Polycythemia Vera);原发性骨髓纤维化(Primary Myelofibrosis);生活质量(Quality of Life);血栓形成(Thrombosis)

DOI 10.1080/14728214.2021.1945579

PMID 34139920

发布时间 2022-01-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Expert opinion on emerging drugs

2021年26卷3期

209-218页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Stepping out of antiquity: An update on emerging drugs for the treatment of polycythemia vera.

Expert opinion on emerging drugs

相似文献

Expert opinion on emerging drugs

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Stepping out of antiquity: An update on emerging drugs for the treatment of polycythemia vera.

Expert opinion on emerging drugs

相似文献

Expert opinion on emerging drugs

相关期刊

检索历史清除